News Releases

Thursday, October 30, 2014

Local researchers helping lead national study evaluating new approach that could slow progression of Alzheimer’s disease

CLEVELAND – University Hospitals (UH) Case Medical Center is participating in a new national Alzheimer’s disease (AD) clinical research study evaluating the potential benefits of an investigational medicine when taken by people with mild-to-moderate AD who are already being treated with donepezil (Aricept). Titled NOBLE, the trial is evaluating an investigational drug, T817MA, which may have the potential to modify the pace of the disease in those who are currently suffering with mild-to-moderate AD. 
 
The advent of NOBLE comes at a time when the AD clinical research community is moving to prevention-oriented trials that do not include people already diagnosed with the disease.  An estimated five million people in the United States already suffer from mild-to-moderate AD, with those numbers growing at an alarming rate. However, no new drug has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of AD since 2003. The NOBLE study was launched to potentially help address this gap in treatment.


Wednesday, October 29, 2014

Study finds knowledge poor about stroke in Uganda

CLEVELAND – A study published in the journal International Scholarly Research Notices (ISRN) Stroke found that overall knowledge about stroke in Uganda was poor, although knowing what to do for a stroke – go to the hospital – was good.
 
Researchers from higher education institutions in Uganda collaborated with those from Case Western Reserve and University Hospitals Case Medical Center to assess residents’ knowledge of stroke symptoms and treatment options. To date, public perception and level of knowledge of stroke warning signs and risk factors in Uganda have not been well studied, and researchers believe this is the first study to do so.  The researchers surveyed 1,600 residents, and found that three-quarters did not know any stroke risk factors and warning signs, or recognize the brain as the organ affected. 
 
“Main findings are that stroke knowledge is poor with some groups being particularly uninformed, individuals do not personally believe stroke is something that can actually happen to them, and few individuals see primary health care workers as a resource for stroke prevention or care,” the authors wrote.


Monday, October 27, 2014

University Hospitals Joins Focus on Flu – Public Awareness Campaign

CLEVELAND – While many Americans are fixated on the threat of Ebola, Cleveland’s health care community wants to remind people to protect themselves against a tangible threat that kills 3,000 to 49,000 Americans annually – influenza. University Hospitals has joined with the City of Cleveland and other local hospitals in a collaborative public awareness effort, Focus on Flu, aimed at educating residents about the importance of flu vaccinations. 
 
Unlike the common cold and many other viral respiratory infections, the flu can cause severe illness and life-threatening complications. It is estimated that in the U.S., each year on average 5% to 20% of the population gets the flu and more than 200,000 people are hospitalized from seasonal flu-related complications.


Friday, October 24, 2014

University Hospitals, Cleveland Clinic, Metrohealth, Sisters of Charity join with City of Cleveland to focus on Influenza

CLEVELAND – At a time when Americans are fixated on the speculative threat of Ebola, Cleveland’s healthcare community wants to remind people to protect themselves against a tangible threat that kills 3,000 to 49,000 Americans annually – influenza.
 
The Focus On Flu campaign is supported by The City of Cleveland, the Cleveland Department of Public Health, Cleveland Clinic, the Cuyahoga County Board of Health, The MetroHealth System, the Sisters of Charity Health System, and University Hospitals (UH). It is designed to inform residents about the real dangers of influenza, the importance of flu vaccinations and where to find flu shots or the nasal spray vaccine.
 
“We are all walking through a very difficult time and we know that Ebola is a very dangerous disease. However, there are many other infectious diseases and these are treatable and preventable. That is why I am asking each of you, if you have not yet, go and get your flu shot today,” said Cleveland Mayor Frank Jackson. “Do your part!”


Wednesday, October 22, 2014

UH Case Medical Center’s REHEARSAAAL trial testing clinical performance in virtual environment

CLEVELAND – Practice makes perfect.
 
University Hospitals (UH) Case Medical Center and Simbionix recently launched a multi-center, randomized study comparing the clinical performance of abdominal aortic aneurysm (AAA) procedures with and without prior rehearsal in a virtual environment for physicians.
 
The study investigates the clinical related performance and cost analysis of AAA procedures performed using standard protocols compared to procedures performed with prior rehearsal. A total of 11 sites across the country are enrolling up to 150 patients who have chosen to have elective endovascular AAA repair.
 
UH Case Medical Center’s Henry Baele, MD, Vascular Surgeon and Assistant Professor of Surgery at Case Western Reserve University School of Medicine, is leading the trial and is optimistic about the system’s potential.



You must be logged in to view this item.



Login

This area is reserved for members of the news media. If you qualify, please update your user profile and check the box marked "Check here to register as an accredited member of the news media". Please include any notes in the "Supporting information for media credentials" box. We will notify you of your status via e-mail in one business day.